marketed quadrivalent inactivated influenza vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for marketed quadrivalent inactivated influenza vaccine, covering 2019-11-13 to 2019-11-13. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of a Recombinant Quadrivalent Influenza Vaccine Versus a Marketed Quadrivalent Inactivated Influenza Vaccine in Children 3 to 17. [Phase 3]